New gene therapy to effectively treat severe heart failure
Washington: American researches have unveiled a new gene therapy that effectively treats severe heart failure.
The SERCA2a (produced as MYDICAR), developed by researchers at Mount Sinai School of Medicine, is designed to stimulate production of an enzyme that enables the failing heart to pump more effectively.
In a Phase II study, SERCA2a injection through a routine minimally invasive cardiac catheterization was safe and showed clinical benefit in treating this patient population and decreasing the severity of heart failure.
The data were recently presented at the Heart Failure Congress of the European Society of Cardiology in Berlin.
Trial investigator Jill Kalman, Associate Professor, Medicine, Cardiology, Director of the Cardiomyopathy Program, Mount Sinai School of Medicine, said: "SERCA2a met the primary endpoints and appears to be safe and effective in people with advanced heart failure.
"There is a significant unmet need for treatments in this patient population, and these data indicate that SERCA2a is a promising option for them."
The CUPID (Calcium Up-regulation by Percutaneous administration of gene therapy In cardiac Disease) trial is a randomized, double-blind, placebo-controlled study, which enrolled 39 patients with advanced heart failure to study the safety and efficacy of SERCA2a.
Patients were randomized to receive SERCA2a gene delivery in one of three doses or placebo and were evaluated over six months.
The treatment is delivered directly to the patient’s heart during a routine outpatient catheterization procedure.
Patients in the SERCA2a group demonstrated improvement or stabilization in symptoms, heart function, and severity of heart failure.
They also saw an increase in time between cardiovascular events and a decrease in frequency of events.
SERCA2a was found to be safe, with no increases in adverse events, disease-related events, laboratory abnormalities, or arrhythmias compared to placebo.
More from India
More from World
More from Sports
More from Entertaiment
- One year of Modi govt: PM promises to fulfil aspirations
- Watch: Mumbai cops find new secret agents in housewives!
- Hundreds die as heat wave continues in India
- Salman Khan attends sister Arpita's wedding reception in Mandi
- 2G scam: Ex-TRAI chief alleges Manmohan Singh had warned him to cooperate
- Pranab Mukherjee defends Bofors scam, says it was just a media trial
- Zee Media's mega survey on Modi govt
- Zee Media Exclusive: Vidya Balan chats about 'Hamari Adhuri Kahani'
- Para athlete Deepa Malik complains of callous service by Air India
- I eat beef, can somebody stop me?: Kiren Rijiju hits back at Naqvi
- Delhi: Visually impaired boy scores 91.4% in CBSE 12th Board exams
- Smriti Irani visits Amethi, promises to pay insurance money to 25,000 women
- MP: 14-year-old boy works as bonded labour since 2009
- One year of Modi govt: Amit Shah addresses media
- UP: Man chops off wife's nose, hair for dowry
- Arpita-Aayush wedding reception: Salman Khan spreads love in Mandi, says `hum aapke hain`
- One year of NDA govt: PM Modi writes open letter to nation, promises to transform India
- CBSE Class 10 Board Result 2015 (cbse.nic.in, cbseresults.nic.in) postponed?
- CBSE Class 10 Board Result 2015 to be announced today
- Check mahresult.nic.in for MSBSHSE Maharashtra Class 12 HSC Result 2015
- MSBSHSE Class 12th HSC results 2015 to be declared at 1pm tomorrow
- Rahul Gandhi takes a dig at one year of Modi govt, wishes 'happy birthday' to 'suit-boot ki sarkar'
- Maharashtra MSBSHSE HSC Result 2015 on mahresult.nic.in
- Bharatiya Janata Party lacks majority for Ram Temple, Article 370: Amit Shah
- AAP govt moves resolution against MHA notification: As it happened
- I was misquoted, says Kiren Rijiju on 'beef' remark
- Heatwave kills 90 more in Andhra, Telangana; toll crosses 800
- CBSE 10th result to be declared tomorrow
- First look: Salman Khan steals thunder in `Bajrangi Bhaijaan`
- mahresult.nic.in updated with MSBSHSE Maharashtra HSC Class XII Result 2015